Table 3 Adverse events in both groups. The treatment (CXL) group showed significantly more haze and corneal erosion during the follow-up period. After 3 years, all but 3 eyes showed a complete resolution of the haze
Placebo group | CXL group | |||
|---|---|---|---|---|
Maximal haze | 0 | 71 % (10) | 0 % (0) | p < 0.01 |
1 | 7 % (1) | 20 % (3) | ||
2 | 21 % (3) | 73 % (11) | ||
3 | 0 % (0) | 7 % (1) | ||
Corneal erosions | 0 | 79 % (11) | 7 % (1) | p < 0.01 |
1 | 0 % (0) | 7 % (1) | ||
2 | 7 % (1) | 13 % (2) | ||
3 | 7 % (1) | 60 % (9) | ||
4 | 7 % (1) | 13 % (2) |